Canaccord Genuity and Barclays Raise Kenvue (KVUE) Price Targets [Yahoo! Finance]
Kenvue Inc. (KVUE)
Company Research
Source: Yahoo! Finance
Barclays analyst Lauren Lieberman pointed out that the company has performed relatively well in the classic consumer health categories, especially Self Care and Essential Health. However, the analyst also noted that the beauty segment requires a different strategy that is focused on premiumization and regimen-focused innovation. According to Barclays, Kenvue Inc. (NYSE:KVUE) has not yet fully developed this type of approach. Canaccord Genuity and Barclays Raise Kenvue (KVUE) Price Targets Earlier, on February 18, Canaccord Genuity also increased its price target on Kenvue Inc. (NYSE:KVUE) from $17 to $18 and maintained its Hold rating. This update came after the company reported Q4 and full-year 2025 results. Q4 sales increased 3.2% year-over-year, beating the Street estimate of 0.4%. Organic sales rose 1.2% compared with the same period last year. All of Kenvue Inc.'s (NYSE:KVUE) segments reported growth in Q4. Additionally, adjusted EPS came in at $0.27, higher than the Stree
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Kenvue Declares Quarterly Cash DividendBusiness Wire
- Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz [Yahoo! Finance]Yahoo! Finance
- Why Kenvue Inc. (KVUE) is One of the Best Cheap Stocks to Buy Under $20 [Yahoo! Finance]Yahoo! Finance
- Kenvue to Announce First Quarter 2026 Results on May 7, 2026Business Wire
- Kenvue (KVUE) had its price target lowered by Citigroup Inc. from $20.00 to $19.00. They now have a "neutral" rating on the stock.MarketBeat
KVUE
Earnings
- 2/17/26 - Beat
KVUE
Sec Filings
- 4/15/26 - Form 8-K
- 4/8/26 - Form ARS
- 4/8/26 - Form DEFA14A
- KVUE's page on the SEC website